Ottawa Hospital Research Institute

Thalassemia

The Ottawa Hospital is conducting cutting-edge research to improve our understanding of thalassemia and develop better approaches for treatment and prevention. This page includes selected news stories about our thalassemia research, links to researchers working in this area and related resources. Learn more below.

Researchers

Name	Scientific appointment	Diseases, conditions and populations of interest	Research and clinical approaches
Berardi, Philip MD, PhD, FRCPC	Clinician Investigator (Cancer Research)	Aging, Anemia, Bleeding disorders, Blood cancer, Cancer, COVID-19, Health equity, Health in older peoples, Sickle cell anemia, Thalassemia, Thrombosis / thromboembolism	Artificial intelligence and data science, Basic research, Bioinformatics, Biomarkers, Cancer biotherapeutics, Cell therapy, Epigenetics, Gene expression, Genetics, Genomics, Immunotherapy, Molecular and cellular biology, Stem cells, Translational research
Brand, Marjorie PhD	Senior Scientist Affiliate (Regenerative Medicine)	Blood cancer, Sickle cell anemia, Thalassemia, Vascular, heart and metabolic disease	Artificial intelligence and data science, Basic research, Bioinformatics, Disease models, Epigenetics, Gene expression, Genomics, Imaging, Model organisms, Molecular and cellular biology, Proteomics, Stem cells, Systems biology, Transgenic/knockout models
Tinmouth, Alan MD, FRCPC, MSc (Clin Epi)	Senior Scientist (Inflammation and Chronic Disease)	COVID-19, Sickle cell anemia, Thalassemia	Clinical trials, Epidemiology, Transfusions

Related Resources

Search for clinical trials at The Ottawa Hospital related to this disease or condition.